Literature DB >> 8819565

Heterogeneity of HIV-1 and HIV-2.

B T Korber1, E E Allen, A D Farmer, G L Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8819565

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  31 in total

1.  Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.

Authors:  A Samri; G Haas; J Duntze; J M Bouley; V Calvez; C Katlama; B Autran
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo.

Authors:  L Zhang; R S Diaz; D D Ho; J W Mosley; M P Busch; A Mayer
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism.

Authors:  M Pope; S S Frankel; J R Mascola; A Trkola; F Isdell; D L Birx; D S Burke; D D Ho; J P Moore
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.

Authors:  Yan Desfosses; Mayra Solis; Qiang Sun; Nathalie Grandvaux; Carine Van Lint; Arsene Burny; Anne Gatignol; Mark A Wainberg; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.

Authors:  Deborah Heydenburg Fuller; Premeela A Rajakumar; Lawrence A Wilson; Anita M Trichel; James T Fuller; Tim Shipley; Mary S Wu; Kathleen Weis; Charles R Rinaldo; Joel R Haynes; Michael Murphey-Corb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

Authors:  A Trkola; A B Pomales; H Yuan; B Korber; P J Maddon; G P Allaway; H Katinger; C F Barbas; D R Burton; D D Ho
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Simian immunodeficiency virus DNA vaccine trial in macaques.

Authors:  S Lu; J Arthos; D C Montefiori; Y Yasutomi; K Manson; F Mustafa; E Johnson; J C Santoro; J Wissink; J I Mullins; J R Haynes; N L Letvin; M Wyand; H L Robinson
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.

Authors:  Sergey Iordanskiy; Mackenzie Waltke; Yanjun Feng; Charles Wood
Journal:  Retrovirology       Date:  2010-10-12       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.